Completed a Bachelor's degree in Chemistry at the Faculty of Philosophy, Sciences, and Letters of Ribeirão Preto - USP (2017), with a sandwich period (2013-2014) at Bowling Green State University, Ohio (USA), funded by the Science Without Borders program (CNPq and CAPES). Completed a Direct Ph.D. at the Faculty of Pharmaceutical Sciences of Ribeirão Preto - USP in 2024, under the supervision of Prof. Ivone Carvalho, with funding from the FAPESP Research Aid Program (2018-2020) and CAPES (2020-2024). Has experience in Medicinal Chemistry, with emphasis on Organic Synthesis and Structure-Activity Relationship of bioactive compounds, focusing primarily on Chagas Disease, Heterocyclic Synthesis, and Cycloaddition Reactions. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Chagas disease is an infectious disease caused by the protozoan Trypanosoma cruzi. In Brazil alone, it is estimated that there are more than 4.5 million people infected. The main therapeutic option currently available is benznidazole. This drug exhibits significant activity in the acute phase of the disease, yet reduced efficacy in the chronic phase (the stage where most cases are diagnos…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID